AlphaCrest Capital Management’s Merit Medical Systems MMSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-10,199
Closed -$576K 711
2022
Q3
$576K Sell
10,199
-20,872
-67% -$1.2M 0.04% 917
2022
Q2
$1.69M Buy
31,071
+15,895
+105% +$970K 0.08% 415
2022
Q1
$1.01M Sell
15,176
-29,855
-66% -$1.8M 0.06% 542
2021
Q4
$2.81M Buy
+45,031
New +$3.02M 0.1% 257
2021
Q3
Sell
-5,368
Closed -$347K 1326
2021
Q2
$347K Sell
5,368
-1,473
-22% -$91.1K 0.01% 1071
2021
Q1
$410K Buy
6,841
+545
+9% +$31.2K 0.02% 893
2020
Q4
$349K Sell
6,296
-8,850
-58% -$457K 0.03% 844
2020
Q3
$659K Buy
15,146
+8,434
+126% +$381K 0.07% 437
2020
Q2
$306K Buy
+6,712
New +$271K 0.05% 621
2020
Q1
Sell
-8,521
Closed -$266K 1175
2019
Q4
$266K Buy
+8,521
New +$244K 0.02% 1120

Other funds holding MMSI

AlphaCrest Capital Management's MMSI Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Merit Medical Systems (MMSI) in Q4 2022, closing a stake of 10,199 shares — an estimated $576K sold.

AlphaCrest Capital Management first reported a position in MMSI in Q4 2019 and held it in 10 quarters. The position peaked at $2.81M in Q4 2021. 279 funds tracked by Wall St. Rank hold MMSI as of Q4 2022.

  • AlphaCrest Capital Management reported no remaining Merit Medical Systems position as of Q4 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 10,199 Merit Medical Systems shares in Q4 2022, an estimated $576K.
  • AlphaCrest Capital Management first reported a position in Merit Medical Systems in Q4 2019 and held it in 10 quarters.
  • AlphaCrest Capital Management's Merit Medical Systems position peaked at $2.81M in Q4 2021.
  • 279 funds tracked by Wall St. Rank held Merit Medical Systems as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.